The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Essential Role of the E3 Ubiquitin Ligase Cbl-b in T Cell Anergy Induction
Open accessAbstract
Antigen-specific immunotolerance limits the expansion of self-reactive T cells involved in autoimmune diseases. Here, we show that the E3 ubiquitin ligase Cbl-b is upregulated in T cells after tolerizing signals. Loss of Cbl-b in mice results in impaired induction of T cell tolerance both in vitro and in vivo. Importantly, rechallenge of Cbl-b mutant mice with the tolerizing antigen results in massive lethality. Moreover, ablation of Cbl-b resulted in exacerbated autoimmunity. Mechanistically, loss of Cbl-b rescues reduced calcium mobilization of anergic T cells, which was attributed to Cbl-b-mediated regulation of PLCgamma-1 phosphorylation. Our results show a critical role for Cbl-b in the regulation of peripheral tolerance and anergy of T cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The E3 ubiquiting ligase family can affect PI3K, mTOR, and Ras/MAPK signaling pathways and help to actively maintain anergy [21,23,24].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [23]
Citations
Cites
Barnden, M., Allison, J., Heath, W. R., & Carbone, F. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00709.x · Cited by 1,491
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.
Kearney, E. R., Pape, K., Loh, D., & Jenkins, M. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 1,126
The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T. R., & Liu, Y. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,036
Self-citationTolerance induction in double specific T-cell receptor transgenic mice varies with antigen
Pircher, H., Bürki, K., Lang, R., Hengartner, H., & Zinkernagel, R. M. (1989) · Nature · doi:10.1038/342559a0 · Cited by 1,019
Structure of a c-Cbl–UbcH7 Complex
Zheng, N., Wang, P., Jeffrey, P. D., & Pavletich, N. P. (2000) · Cell · doi:10.1016/s0092-8674(00)00057-x · Cited by 839
Transcriptional Mechanisms Underlying Lymphocyte Tolerance
Macián, F., Garcia-Cozar, F. J., Im, S., Horton, H. F., Byrne, M. C., & Rao, A. (2002) · Cell · doi:10.1016/s0092-8674(02)00767-5 · Cited by 687
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
Bachmaier, K., Krawczyk, C. M., Kozieradzki, I., Kong, Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A. C., Itié, A., et al. (2000) · Nature · doi:10.1038/35003228 · Cited by 674
Self-citationCbl: many adaptations to regulate protein tyrosine kinases
Thien, C. B. F., & Langdon, W. Y. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067100 · Cited by 628
Cbl-b regulates the CD28 dependence of T-cell activation
Chiang, Y. J., Kole, H. K., Brown, K. E., Naramura, M., Fukuhara, S., Hu, R.-J., Jang, I. K., Gutkind, J. S., Shevach, E. M., & Gu, H. (2000) · Nature · doi:10.1038/35003235 · Cited by 626
Flagged first, then by citations
Research works printed but not linked: 1
- Keane, 1995, Cloning and characterization of cbl-b, Oncogene, 10, 2367
Cited by
Sorted by citations
Items 201–300 of 349
ZAP-70 Regulates Autoimmune Arthritis via Alterations in T Cell Activation and Apoptosis
Kugyelka, R., Prenek, L., Olasz, K., Kohl, Z., Botz, B., Glant, T. T., Berki, T., & Boldizsár, F. (2019) · Cells · doi:10.3390/cells8050504 · Cited by 17
CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells
Gol, T. M., Kim, M., Sinn, R., Ureña-Bailén, G., Stegmeyer, S., Gratz, P. G., Zahedipour, F., Roig‐Merino, A., Antony, J. S., & Mezger, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216065 · Cited by 16
Till, S. J., Raynsford, E. J., Reynolds, C. J., Quigley, K. J., Grzybowska-Kowalczyk, A., Saggar, L. R., Goldstone, A., Maillère, B., Kwok, W. W., Altmann, D. M., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-204324 · Cited by 16
Goetz, B. T., An, W., Mohapatra, B. C., Zutshi, N., Iseka, F., Storck, M. D., Meza, J. L., Sheinin, Y. M., Band, V., & Band, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9812 · Cited by 16
Han, S., Chung, D. C., Paul, M. S., Liu, Z. Q., Garcia-Batres, C. R., Elford, A. R., Tran, C. W., Chapatte, L., & Ohashi, P. S. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1737368 · Cited by 16
Self-citationThe Role of the E3 Ligase Cbl-B in Murine Dendritic Cells
Wallner, S., Lutz‐Nicoladoni, C., Tripp, C. H., Gastl, G. A., Baier, G., Penninger, J. M., Stoitzner, P., & Wolf, D. G. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065178 · Cited by 16
Self-citationNdfip1 Enforces a Requirement for CD28 Costimulation by Limiting IL-2 Production
Ramos-Hernández, N., Ramón, H. E., Beal, A. M., Laroche, A., Dekleva, E. A., & Oliver, P. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203571 · Cited by 16
Ubiquitylation as a Rheostat for TCR Signaling: From Targeted Approaches Toward Global Profiling
O’Leary, C. E., Lewis, E. L., & Oliver, P. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00618 · Cited by 15
Autoreactive CD8 T cells in NOD mice exhibit phenotypic heterogeneity but restricted TCR gene usage
Kasmani, M. Y., Ciecko, A. E., Brown, A. K., Петрова, Г. В., Gorski, J., Chen, Y., & Cui, W. (2022) · Life Science Alliance · doi:10.26508/lsa.202201503 · Cited by 14
Shiner, E. K., Holbrook, B. C., & Alexander‐Miller, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100175 · Cited by 15
The Ubiquitin E3 Ligase Cbl-b in T Cells Tolerance and Tumor Immunity
Loeser, S., & Penninger, J. M. (2007) · Cell Cycle · doi:10.4161/cc.6.20.4797 · Cited by 15
Self-citationGlycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation
Tran, C. W., Saibil, S. D., Bihan, T. L., Hamilton, S. R., Lang, K. S., You, H., Lin, A. E., Garza, K. M., Elford, A. R., Tai, K., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600396 · Cited by 15
Self-citationAsashima, H., Tsuboi, H., Takahashi, H., Hirota, T., Iizuka, M., Kondo, Y., Matsui, M., Matsumoto, I., & Sumida, T. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39163 · Cited by 15
Podojil, J. R., Turley, D. M., & Miller, S. D. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-09789-3_18 · Cited by 15
Cbl‐family proteins as regulators of cytoskeleton‐dependent phenomena
Lee, H., & Tsygankov, A. Y. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24412 · Cited by 14
Yoon, J.-S., & Lee, C.-W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00883-0 · Cited by 14
Schartner, J. M., Simonson, W. T., Wernimont, S. A., Nettenstrom, L. M., Anna Huttenlocher, A., & Seroogy, C. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024497 · Cited by 14
Does Antigen Masking by Ubiquitin Chains Protect from the Development of Autoimmune Diseases?
Weil, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00262 · Cited by 14
E3 ubiquitin ligases and their control of T cell autoreactivity.
Bonnevier, J. L., Zhang, R., & Mueller, D. L. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1842 · Cited by 14
CD43 regulates the threshold for T cell activation by targeting Cbl functions
Pedraza‐Alva, G., de Long, L. M., del Río, R., Fierro, N. A., Muñoz, M. E. C., Olivares, N., Melchy-Pérez, E., Igras, V., Holländer, G. A., Burakoff, S. J., et al. (2011) · IUBMB Life · doi:10.1002/iub.554 · Cited by 14
Nanjappa, S. G., Mudalagiriyappa, S., Fites, J. S., Suresh, M., & Klein, B. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701241 · Cited by 13
E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
Poels, K., Vos, W. G., Lutgens, E., & Seijkens, T. T. P. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00106 · Cited by 11
Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism
Qiao, G., Yang, L., Li, Z., Ying, H., Hassen, Y., Yin, F., & Zhang, J. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.02.006 · Cited by 13
Wagle, M. V., Marchingo, J. M., Howitt, J. A., Tan, S., Goodnow, C. C., & Parish, I. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.060 · Cited by 12
Li, Y., Qu, X., Qu, J., Ye, Z., Jing, L., Yuee, T., Hu, X., Hou, K., & Liu, Y. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500142 · Cited by 12
Self-citationBrembilla, N. C., Weber, J., Rimoldi, D., Pradervand, S., Schütz, F., Pantaleo, G., Rüegg, C., Quadroni, M., Harshman, K., & Doucey, M. (2008) · Blood · doi:10.1182/blood-2008-01-134486 · Cited by 12
Preservation of self: An overview of E3 ubiquitin ligases and T cell tolerance
Schartner, J. M., Fathman, C. G., & Seroogy, C. M. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.010 · Cited by 12
Self-citationLck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event
Sanctis, J. B. D., Garmendia, J. V., Duchová, H., Valentini, V., Puskasu, A., Kubíčková, A., & Hajdúch, M. (2024) · Cancers · doi:10.3390/cancers16152630 · Cited by 11
Foxp3 positive regulatory T cells: a functional regulation by the E3 ubiquitin ligase Itch
Su, J., & Liu, Y. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0192-1 · Cited by 12
Self-citationPatel, T., Henrickson, S. E., Moser, E. K., Field, N. S., Maurer, K., Dawany, N. B., Conrad, M. A., Bunin, N., Freedman, J. L., Heimall, J. R., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.04.010 · Cited by 11
Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1
Zhou, L., Ye, X., Wang, K., Shen, H., Wang, T., Zhang, X., Jiang, S., Xiao, Y., & Zhang, K. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106682 · Cited by 11
Mohib, K., Al-Khamees, B., Zein, H. S., Allan, D., & Wang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032420 · Cited by 11
Tarner, I. H., & Fathman, C. G. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0272 · Cited by 11
Self-citationFarhangnia, P., & Akbarpour, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00165-8 · Cited by 15
Rodríguez, R. M. A., Hernández-Fuentes, M. P., Corte-Iglesias, V., Sáiz, M. L., Lozano, J. J., Cortázar, A. R., Mendizabal, I., Suárez-Fernández, M. L., Coto, E., López‐Vázquez, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.709164 · Cited by 10
Zeng, Q., Tang, N., Ma, Y., Guo, H., Zhao, Y., Tang, R., Yan, C., Ouyang, S., Langdon, W. Y., Yang, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105151 · Cited by 11
Therapeutic Potential of Hyporesponsive CD4+ T Cells in Autoimmunity
Maggi, J., Schäfer, C., Ubilla-Olguín, G., Catalán, D., Schinnerling, K., & Aguillón, J. C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00488 · Cited by 10
Yang, T., Martin, M. L., Nielsen, J. S., Milne, K., Wall, E. M., Lin, W., Watson, P. H., & Nelson, B. H. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0698-3 · Cited by 10
Zha, Y., & Gajewski, T. F. (2007) · Cellular Immunology · doi:10.1016/j.cellimm.2007.07.006 · Cited by 10
Biomarkers to Discern Transplantation Tolerance after Allogeneic Hematopoietic Cell Transplantation
Pidala, J., Bloom, G. C., Enkemann, S. A., Eschrich, S. A., Lancaster, J. M., & Anasetti, C. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.11.009 · Cited by 9
Policheni, A. N., Horikawa, K., Milla, L., Kofler, J., Bouillet, P., Belz, G. T., O’Reilly, L. A., Goodnow, C. C., Strasser, A., & Gray, D. H. D. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12268 · Cited by 9
Immune Regulation by Ubiquitin Conjugation
Venuprasad, K., Yang, C., Shao, Y., Demydenko, D., Harada, Y., Jeon, M., & Liu, Y. (2007) · Springer eBooks · doi:10.1007/0-387-34132-3_15 · Cited by 9
Self-citationE3 ubiquitin ligase Cbl‐b suppresses human ORMDL3 expression through STAT6 mediation
Yang, W., Jin, R., Jiang, C., Wang, X., Shu, J., Li, L., Zhu, L.-H., Zhuang, L., Gao, C., & Zhou, G.-P. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.06.015 · Cited by 9
Zhang, G., Yu, S., Calida, D. M., Zhao, Z., Gran, B., Kamoun, M., & Rostami, A. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3366 · Cited by 9
Barrera‐Vargas, A., Gómez‐Martín, D., & Alcocer-Varela, J. C. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.08.207 · Cited by 9
Rose, M. S., Qui, H. Z., Bandyopadhyay, S., Mihalyo, M. A., Hagymasi, A. T., Clark, R. B., & Adler, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901243 · Cited by 9
Innate (Over)immunity and Adaptive Autoimmune Disease
Recher, M., & Lang, K. S. (2006) · Current topics in microbiology and immunology · doi:10.1007/3-540-29714-6_5 · Cited by 9
Redmond, W. L., & Linch, S. N. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1193277 · Cited by 9
NDRG1 is induced by antigen-receptor signaling but dispensable for B and T cell self-tolerance
Hodgson, R., Xu, X., Anzilotti, C., Deobagkar‐Lele, M., Crockford, T. L., Kepple, J. D., Cawthorne, E., Bhandari, A., Cebrian-Serrano, A., Wilcock, M. J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04118-w · Cited by 8
ADACHI, Y., Hattori, M., & Yoshida, T. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100107 · Cited by 8
Cbl-b Deficiency in Mice Results in Exacerbation of Acute and Chronic Stages of Allergic Asthma
Carson, W. F., Guernsey, L. A., Singh, A., Secor, E. R., Wohlfert, E. A., Clark, R. B., Schramm, C. M., Kunkel, S. L., & Thrall, R. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00592 · Cited by 8
Lineberry, N. B., & Fathman, C. G. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.002 · Cited by 8
Self-citationVos, W. G., van Os, B. W., den Toom, M., Beckers, L., van Roomen, C. P. A. A., van Tiel, C. M., Mohapatra, B. C., Band, H., Nitz, K., Weber, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1297893 · Cited by 7
Fujiwara, M., Anstadt, E. J., Khanna, K. M., & Clark, R. B. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.018 · Cited by 7
Zd, S., Xf, L., Hao, L., Zhao, Y., Yx, W., Dong, B.-Z., Wh, C., Zg, Z., Ym, W., Fu, Q., et al. (2014) · PubMed · Cited by 7
Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-b
Peer, S., Cappellano, G., Hermann‐Kleiter, N., Albrecht-Schgoer, K., Hinterleitner, R., Baier, G., & Gruber, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02311 · Cited by 7
Manipulating the TCR signaling network for cellular immunotherapy: Challenges & opportunities
Matson, C. A., & Singh, N. J. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.04.007 · Cited by 7
Zhang, Y., Guan, X., Chai, Y., Lu, T., An, N., Lin, X., & Liao, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117488 · Cited by 6
Cbl-b inhibitor NX-1607 activates MAPK/ERK signaling pathway and enhances T-cell activation
Zhu, W., Lu, S., Jia, L., Liu, B., Song, S., Bao, X., Yu, T. Y., Zhang, Y., Miao, Z., & He, J. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011180 · Cited by 6
Zhang, B., & Chen, S. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.020 · Cited by 6
Hu, L.-B., Hu, X.-Q., Zhang, Q., You, Q., & Jiang, Z. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116130 · Cited by 6
Immune Regulation by Ubiquitin Tagging as Checkpoint Code
Zeng, P., Ma, J., Yang, R., & Liu, Y. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_64 · Cited by 6
Self-citationJönsson, V. D., Ng, R. H., Dullerud, N., Wong, R. A., Hibbard, J. C., Wang, D., Aguilar, B., Starr, R., Weng, L., Alizadeh, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.22.460392 · Cited by 6
SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling
Hamaidi, I., Cheng, P., Jun, S. Y., Manna, A., Wang, M.-H., Nguyen, A., Can, İ., Zhang, M., Taylor, O. O., Lopez-Bailon, L. U., et al. (2026) · Nature Immunology · doi:10.1038/s41590-025-02377-3 · Cited by 5
The Role of Ubiquitin-Proteasome System (UPS) in Asthma Pathology
Deng, S., Ding, L., Qian, Y., & Huang, X. (2025) · Journal of Asthma and Allergy · doi:10.2147/jaa.s490039 · Cited by 6
Xu, F., Tan, C., Tang, K., Qiao, G., Shao, Y., Li, X., Zhou, J. Y., Zhu, P., Wu, M., Cai, J., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08047-4 · Cited by 5
E3 Ligases in T Helper 2-mediated Pathogenesis
Sahoo, A. (2014) · Immunome Research · doi:10.4172/1745-7580.1000086 · Cited by 5
Yu, J., Zhao, H., Zhang, Y., Liu, Y., Yao, L., Li, X., & Su, J. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.003 · Cited by 5
Self-citationAnimal Models: Systemic Autoimmune Diseases
Mizui, M., & Tsokos, G. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00029-4 · Cited by 5
Dendritic Cell Immune Therapy to Break or Induce Tolerance
Amodio, G., Annoni, A., & Gregori, S. (2015) · Current Stem Cell Reports · doi:10.1007/s40778-015-0024-2 · Cited by 5
Mechanisms of self-inactivation in anergic T cells
Valdor, R., & Macián, F. (2010) · Inmunología · doi:10.1016/s0213-9626(10)70008-1 · Cited by 7
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells
Zheng, Y., Yu, M., Chen, Y., Xue, L., Zhu, W., Fu, G., Morris, S. W., Wen, R., & Wang, D. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200639 · Cited by 4
Seo, S., Hattori, M., & Yoshida, T. (2024) · Cytotechnology · doi:10.1007/s10616-024-00651-0 · Cited by 4
Eisenberg‐Lerner, A., Regev, I., & Merbl, Y. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7201-2_9 · Cited by 4
Sriram, S., Krishnakumar, P., & Sudandiradoss, C. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1745654 · Cited by 3
Wang, J., Han, X., Hao, Y., Chen, S., Pang, B., Zou, L., Han, X., Wang, W., Liu, L.-Z., Shen, M., et al. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104863 · Cited by 3
Liu, L., Xiang, Y., Shao, L., Yuan, C., Song, X., Sun, M., Liu, Y., Zhang, X., Du, S., Hou, M., et al. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.12.032 · Cited by 3
Self-citationNath, P. R., & Isakov, N. (2024) · Life · doi:10.3390/life14121592 · Cited by 3
Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
Sioud, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_15 · Cited by 3
Shiheido, H., Aoyama, T., Takahashi, H., Hanaoka, K., Abe, T., Nishida, E., Chen, C., Koga, O., Hikida, M., Shibagaki, Y., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344146 · Cited by 3
Cbl-b: Roles in T Cell Tolerance, Proallergic T Cell Development, and Cancer Immunity
JoAnn Trial, L. A. P. (2014) · Inflammation and Cell Signaling · doi:10.14800/ics.146 · Cited by 3
Tomar, N., & De, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080918 · Cited by 3
Iwata, Y., Matsushita, T., Narushima, Y., Harada, A., Sakamoto, Y., Sakamoto, A., Ikegami, H., Mishima, M., & Suzuki, H. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4812 · Cited by 2
Regulation of T Cell Differentiation and Allergic Responses by the E3 Ubiquitin Ligase Itch
Liu, Y. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_106 · Cited by 2
Self-citationESCI award lecture: from a little mouse to rationale medicine for bone loss
Leibbrandt, A., & Penninger, J. M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02215.x · Cited by 2
Self-citationJuan, M. (2016) · MOJ Immunology · doi:10.15406/moji.2016.04.00113 · Cited by 2
Grossman, M. A., Hofmann, C., Ng, H. L., & Yang, O. O. (2019) · AIDS · doi:10.1097/qad.0000000000002259 · Cited by 2
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
Beck, J. D., Birtel, M., Haefner, E. S., Keil, I. S., Reidenbach, D., Salomon, N., Yildiz, I., & Diken, M. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1675459 · Cited by 2
Li, R., Guo, H., Hou, Y., Liu, S., Wang, M., Peng, T., Zhao, X., Lu, L., Han, Y., Shao, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.988253 · Cited by 2
Victora, G. D., Chudnovskiy, A., Nakandakari-Higa, S., Castro, T. B. R., Cui, A., Lin, C., Sade-Feldman, M., Phillips, B. K., Pae, J., Mesin, L., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2152423/v1 · Cited by 2
Peripheral Tolerance of T Cells in the Mouse
Heissmeyer, V., Tanasă, B., & RAO, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50088-1 · Cited by 2
Lu, S., Zhu, W.-T., Song, S.-S., Bao, X., Yu, T. Y., Zhang, Y., Miao, Z., & He, J. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112051 · Cited by 1
Li, Y., Tang, H., Shi, W., Zhou, Y., Wen, J., Zhu, J., Gao, M., Xu, T., & Xie, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116026 · Cited by 1
Post‐Translational Regulation of CD8 + T Cell Fate and Dysfunction in Tumor Immunity
Zhou, Z., Chen, X., Li, N., Zou, M., Lin, Y., Lin, P., Feng, W., Zhao, X., & Cui, L. (2026) · Advanced Science · doi:10.1002/advs.74807 · Cited by 1
Tolerance and Autoimmunity: T Cells
Gronski, M. A., & Ohashi, P. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50011-1 · Cited by 1
Self-citationOrtiz, Y. M., García, L. F., & Álvarez, C. M. (2012) · Clinical Transplantation · doi:10.1111/j.1399-0012.2012.01683.x · Cited by 1
The Role of NDFIP1 in T Cell Tolerance
Hernández, R., & Natalia, M. (2013) · Cited by 1
Discoidin Domain Receptor Signalling Networks
Iwai, L. K., Payne, L. S., Allam, D., & Huang, P. H. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6383-6_11 · Cited by 1
Wang, B., Zhou, J., & An, N. (2024) · PeerJ · doi:10.7717/peerj.17280 · Cited by 1
Xiao, X., Xie, R., Zhang, Y., Yin, Y., Chen, Y., Sun, N., Cheng, Z., & Zhang, G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167765 · Cited by 1
Metadata
- Authors
- Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., Bouchard, D., Jones, R., Gronski, M., Ohashi, P., Wada, T., Bloom, D., Fathman, C. G., Liu, Y.-C., & Penninger, J. M.
- Affiliations
- La Jolla Institute for Immunology (US)
- University of Toronto (CA)
- Institute of Molecular Biotechnology (AT)
- Stanford Medicine (US)
- Corresponding author
- Liu, Yun-Cai
- Penninger, Josef M.
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 21
- Issue
- 2
- Pages
- 167-177
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2039096179
- Cited by
- 348
- References
- 33
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 5 · 2022: 8 · 2021: 16 · 2020: 12 · 2019: 13 · 2018: 10 · 2017: 15 · 2016: 12 · 2015: 19 · 2014: 23 · 2013: 22 · 2012: 20
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ai050280-05)
- U.S. Public Health Service (R0156558)
- National Institute of Allergy and Infectious Diseases (R01 AI 50280)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Cbl-b, E3 ubiquitin ligase, T cell anergy, T cell tolerance, antigen-specific tolerance, autoimmunity, calcium mobilization, peripheral tolerance, autoreactive T cells
- MeSH terms
- Animals, Antigens, Enterotoxins, Type C Phospholipases, T-Lymphocytes, Clonal Anergy, Adoptive Transfer, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-cbl, Mice, Phospholipase C gamma, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review